drugset / Trial / NCT02480335

The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis

NCT02480335

RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study is to investigate whether bosentan added to usual care improves arterial stiffness after 3 months as measured as the pulse wave velocity (PWV) of the medium and large arteries corrected for blood pressure changes in patients with systemic sclerosis (SSc) with digital ulcers (DU). Patients will be randomized into a group with usual care and bosentan (n=10) or usual care only (n=10). PWV will be assessed at baseline, 3 months and 12 months.

Timeline

Start
2015-06-26
Primary completion
2018-07-30
Completion
2018-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Bosentan Other / unclassified 125 mg Oral

Indications